Skip to content
StockMarketAgent
Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

IST/EGEPO stock hub

IST/EGEPO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

IST/EGEPOis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
9.5B
Istanbul Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
IST/EGEPO
In the news

Latest news · IST/EGEPO

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 13.7P50 15.1P75 15.3
Trailing P/E3,580.9
P25 16.6P50 25.2P75 56.6
ROE0.1
P25 -2.4P50 3.5P75 11.2
ROIC0.9
P25 -0.7P50 4.3P75 13.6
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All IST/EGEPO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
192
Groups with data
10
Currency
TRY
Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Turkey
Country code
TR
Employees
658
Employees Change
-58%
Employees Change Percent
-8.1
Enterprise value
TRY 9.4B
Exchange
Istanbul Stock Exchange
Financial currency
TRY
First seen
2026-05-10
Industry
Medical Care Facilities
Isin
TRENSMD00029
Last refreshed
2026-05-10
Market cap
TRY 9.5B
Price
TRY 19.07
Price currency
TRY
Rev Per Employee
2,044,852.28x
Sector
Healthcare
Sic
8060
Symbol
ist/EGEPO
Website
https://www.egepolhastanesi.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
0.03%
EV Earnings
3,534.06x
EV/EBIT
78.29x
EV/EBITDA
32.16x
EV/FCF
-472.06x
EV/Sales
6.99x
FCF yield
-0.21%
P/B ratio
5x
P/E ratio
3,580.86x
P/S ratio
7.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
8.93%
EBITDA Margin
20.73%
Gross margin
16.26%
Gross Profit
TRY 218.8M
Gross Profit Growth
-27.89%
Gross Profit Growth Q
30.45%
Gross Profit Growth3 Y
40.48%
Gross Profit Growth5 Y
39.06%
Net Income
TRY 2.7M
Net Income Growth5 Y
-39.53%
Pretax Margin
1.49%
Profit Margin
0.2%
Profit Per Employee
TRY 4,047
ROA
3.32
Roa5y
4.58
ROCE
5.7
ROE
0.14
Roe5y
-1.32
ROIC
0.93
Roic5y
8.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr1y
165.04%
Cagr3y
77.91%
EPS Growth5 Y
-42.17
FCF Growth Q
-66.82%
OCF Growth
-54.4%
OCF Growth Q
-38.01%
OCF Growth5 Y
29.99%
Revenue Growth
1.88x
Revenue Growth Q
3.56x
Revenue Growth3 Y
39.19x
Revenue Growth5 Y
63.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
TRY 0.59
Assets
TRY 2.3B
Cash
TRY 166.6M
Current Assets
TRY 364.1M
Current Liabilities
TRY 202.1M
Debt
TRY 42M
Debt EBITDA
TRY 0.14
Debt Equity
TRY 0.02
Debt FCF
TRY -2.11
Equity
TRY 1.9B
Interest Coverage
9.37
Liabilities
TRY 401.6M
Long Term Assets
TRY 1.9B
Long Term Liabilities
TRY 199.5M
Net Cash
TRY 124.6M
Net Cash By Market Cap
TRY 1.31
Net Cash Growth
3.13%
Net Debt EBITDA
TRY -0.45
Net Debt Equity
TRY -0.07
Tangible Book Value
TRY 1.7B
Tangible Book Value Per Share
TRY 3.5
WACC
7.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.8
Inventory Turnover
99.75
Net Working Capital
TRY -1.1M
Quick ratio
1.64
Working Capital
TRY 162M
Working Capital Turnover
TRY 8.71

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
164.86%
200-day SMA
10.24
3Y total return
463.37%
50-day SMA
15.16
50-day SMA vs 200-day SMA
50over200
All Time High
20.1
All Time High Change
-5.12%
All Time High Date
2026-05-07
All Time Low
1.23
All Time Low Change
1,450.41%
All Time Low Date
2021-11-03
ATR
0.72
Beta
0.62
Beta1y
0.27
Beta2y
0.23
Ch YTD
132.8
High
19.31
High52
20.1
High52 Date
2026-05-07
High52ch
-5.12%
Low
18.75
Low52
5.79
Low52 Date
2025-06-19
Low52ch
229.36%
Ma50ch
25.77%
Price vs 200-day SMA
86.29%
RSI
76.59
RSI Monthly
85.35
RSI Weekly
90.56
Sharpe ratio
2.22x
Sortino ratio
4.45
Tr YTD
132.8
Tr1m
35.25%
Tr1w
2.53%
Tr3m
76.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
TRY 120.2M
Operating Income Growth
-20.61
Operating Income Growth Q
-44.65
Operating Income Growth3 Y
51.41
Operating Income Growth5 Y
27.19
Operating margin
8.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

4
MetricValue
Net Borrowing
-22,635,711
Shares Insiders
78.93%
Shares Out
500,000,000
Shares Qo Q
0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
TRY -19.9M
Average Volume
3,875,678.2x
Bv Per Share
3.82
CAPEX
TRY -139.6M
Ch1m
35.25
Ch1w
2.53
Ch1y
164.9
Ch3m
76.57
Ch3y
463.4
Ch6m
150.3
Change
-0.05%
Change From Open
-1.19
Close
19.08
Days Gap
1.15
Depreciation Amortization
158,679,471
Dollar Volume
50,004,324.2
Earnings Date
2026-05-14
EBIT
TRY 120.2M
EBITDA
TRY 278.9M
EPS
TRY 0.01
F Score
5
FCF
TRY -19.9M
FCF EV Yield
-0.21x
FCF Per Share
TRY -0.04
Financing CF
2,365,369
Fiscal Year End
December
Founded
2,003
Graham Number
0.67611
Graham Upside
-96.45
Income Tax
TRY 17.4M
Investing CF
-201,200,792
Is Primary Listing
1
Last Earnings Date
2026-02-27
Last Report Date
2025-12-31
Last Split Date
2025-03-19
Last Split Type
Forward
Lynch Fair Value
TRY 0.03
Lynch Upside
-99.86
Ma150
10.81
Ma150ch
76.41%
Ma20
17.73
Ma20ch
7.53%
Net CF
-31,473,436
Next Earnings Date
2026-05-14
Open
19.3
P OCF Ratio
79.66
Position In Range
57.14
Ppne
1,773,209,002
Price Date
2026-05-08
Price EBITDA
TRY 34.19
Ptbv Ratio
5.46
Relative Volume
0.68x
Revenue
1,345,512,803x
Tax By Revenue
1.29x
Tax Rate
86.73%
Tr6m
150.26%
Volume
2,622,146
Z Score
6.43
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does IST/EGEPO pay a dividend?

Capital-return profile for this ticker.

Performance

IST/EGEPO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+164.9%
S&P 500 1Y: n/a
3Y total return
+463.4%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns IST/EGEPO?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+78.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

IST/EGEPO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
76.6
Above 70: short-term overbought
Price vs 200-day MA
+86.3%
50/200-day relationship not available
Beta (5Y)
0.62
Less volatile than the market
Sharpe ratio
2.22
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About IST/EGEPO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ist/EGEPO stock rating?

ist/EGEPO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ist/EGEPO analysis?

The full report lives at /stocks/ist/EGEPO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ist/EGEPO?

The latest report frames ist/EGEPO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ist/EGEPO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

ist/EGEPO stock profile: metrics, valuation and analysis | Aktienmarkt-Agent KI